Related Experiment Video

Updated: May 22, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Anemia and chronic kidney disease: making sense of the recent trials

Vinayak Ramanath1, Diptesh Gupta, Juhi Jain

  • 1Department of Internal Medicine, Hospital Drive, Columbia, MO 65211, USA. Ramanathv@health.missouri.edu

Reviews on Recent Clinical Trials
|May 1, 2012
PubMed

Insights

Anemia in chronic kidney disease (CKD) is common and linked to heart issues. This review covers anemia causes, diagnosis, and the safety and effectiveness of erythropoiesis-stimulating agents (ESAs) for CKD patients.

Area of Science:

  • Nephrology
  • Hematology

Background:

  • Anemia is a frequent complication of chronic kidney disease (CKD), significantly increasing cardiovascular disease risk and reducing quality of life.
  • Anemia in CKD is often multifactorial, not solely due to renal insufficiency, making diagnosis challenging.

Purpose of the Study:

  • To review the pathophysiology and diagnosis of anemia in CKD patients.
  • To evaluate the current role, safety, and efficacy of erythropoiesis-stimulating agents (ESAs) in managing anemia of CKD.

Main Methods:

  • This is a review article.
  • Literature search on anemia in CKD, erythropoietin (EPO) deficiency, and erythropoiesis-stimulating agents (ESAs).

Main Results:

  • Anemia diagnosis in CKD can be complex, with EPO deficiency being a diagnosis of exclusion.
  • Erythropoiesis-stimulating agents (ESAs) are primary treatments, but recent trials question their use for higher hemoglobin (Hb) targets due to adverse outcomes.

Conclusions:

  • Understanding the pathophysiology and diagnostic challenges of anemia in CKD is crucial.
  • The role and safety of ESAs in CKD anemia require careful consideration, balancing efficacy with potential risks, especially concerning Hb targets.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...